• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Public Workshop on Minimal Residual Disease (MRD) as a Surrogate Endpoint in Chronic Lymphocytic Leukemia (CLL)

Date:            February 27, 2013

Time:            8:00 a.m. to 4:00 p.m.

Location:     FDA White Oak Campus
                      10903 New Hampshire Avenue,
                      Bldg. 31, Room 1503
                      Silver Spring, Maryland 20993

Meeting Information on MRD in ALL held on April 18, 2012

Webcast of the Meeting

For those unable to attend in person, the meeting will also be webcast. Watch the webcast on February 27, 2013 from 8:00 am to 4:00 pm. Requirements and instructions for accessing the webcast are below.

Meeting Recordings

You may access the webcast via this link:
https://collaboration.fda.gov/cllworkshop/

Adobe Connect Minimum Requirements:

  • View meetings on Windows, Macs, Unix, and Linux platforms
  • Lan or Broadband internet connection
  • Supports Internet Explorer, Firefox, Safari, Netscape Navigator, AOL
  • Adobe Flash Player (no other downloads needed)
  • VPN and Parachute compatible but not required
  • Test my computer for Adobe Connect-Readiness

Vistor Information

All meeting attendees must enter through Building 1 on the FDA White Oak Campus. Parking is available in the Southeast surface lot and a shuttle bus will be available to bring attendees from the lot to Building 1. Please see Directions/Transportation/Parking/Hotels for the FDA White Oak Campus (PDF - 115KB) for directions and further details about transportation and lodging.

Here is a map of the campus Map of White Oak Visitor Parking (PDF - 105KB)

Lunch and Refreshments

Coffee, water, and light snacks will be available for a nominal fee starting at 7:15 a.m., again at 10:05, and for a final time at 2:10 p.m. 

Salads and sandwiches will also be available for purchase during the lunch break at 11:50.

Registration Information

There is no registration fee for the public workshop. To register electronically, please use the following website: http://s.zoomerang.com/Survey/WEB22GPA3U95QX disclaimer icon

For Further Information Contact

Christine Lincoln, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20903, 301-796-4117, Christine.Lincoln@fda.hhs.gov